- $317.77bn
- $361.24bn
- $65.01bn
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
Eli Lilly, Pfizer slip after US House panel probing China clinical trials
US House committee opens investigation into Merck, AbbVie China drug trials (updated)
Brief: U.S. House Committee Sends Letters To Pfizer, Eli Lilly & Bristol Myers Squibb Probing China Drug Trials
U.S. STOCKS ON THE MOVE-Oklo, Fortune Brands, Air Products
Merck, AbbVie slip after Reuters reports US House panel probing China clinical trials
U.S. STOCKS ON THE MOVE-AeroVironment, Oklo
Merck, AbbVie slip after Reuters reports US House panel probing China clinical trials
US House committee opens investigation into Merck, AbbVie China drug trials
US starts vaccine effort for Ebola Bundibugyo as outbreak spreads (updated)
US to ship experimental Ebola therapy to DRC and Uganda as outbreak worsens
Advisory: Alerts incorrectly tagged to Merck & Co withdrawn
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Pfizer's experimental drug misses main goal of lung cancer trial (updated)
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Merck's bowel disease drug meets main goal in late-stage trial (updated)
Merck's bowel disease drug meets main goal in late-stage trial
Brief: Merck’S Tulisokibart Met Primary And Key Secondary Endpoints In The Phase 3 Atlas-Uc Induction-Only Study In Patients With Moderately To Severely Active Ulcerative Colitis (Uc)
U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, Visteon